DE1225647B - Verfahren zum Herstellen von wasserloeslichen Komplexverbindungen des Isonicotinsaeurehydrazons - Google Patents
Verfahren zum Herstellen von wasserloeslichen Komplexverbindungen des IsonicotinsaeurehydrazonsInfo
- Publication number
- DE1225647B DE1225647B DEC24100A DEC0024100A DE1225647B DE 1225647 B DE1225647 B DE 1225647B DE C24100 A DEC24100 A DE C24100A DE C0024100 A DEC0024100 A DE C0024100A DE 1225647 B DE1225647 B DE 1225647B
- Authority
- DE
- Germany
- Prior art keywords
- water
- hydroxy
- isonicotinic acid
- solution
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title claims description 15
- 150000001875 compounds Chemical class 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 4
- 239000000243 solution Substances 0.000 claims description 29
- 150000003839 salts Chemical class 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 9
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical compound C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- -1 1-isopropyl-3-hydroxy-5,6-diketotetrahydroindole Chemical compound 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003873 salicylate salts Chemical class 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 1
- RPHLQSHHTJORHI-UHFFFAOYSA-N Adrenochrome Chemical compound O=C1C(=O)C=C2N(C)CC(O)C2=C1 RPHLQSHHTJORHI-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2917860A | 1960-05-16 | 1960-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1225647B true DE1225647B (de) | 1966-09-29 |
Family
ID=21847656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEC24100A Pending DE1225647B (de) | 1960-05-16 | 1961-05-12 | Verfahren zum Herstellen von wasserloeslichen Komplexverbindungen des Isonicotinsaeurehydrazons |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE603790A (enrdf_load_stackoverflow) |
| DE (1) | DE1225647B (enrdf_load_stackoverflow) |
| FR (1) | FR1139M (enrdf_load_stackoverflow) |
| GB (1) | GB911727A (enrdf_load_stackoverflow) |
| NL (1) | NL264722A (enrdf_load_stackoverflow) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1039708B (de) | 1953-05-19 | 1958-09-25 | Internat Hormones Inc | Verfahren zur Herstellung eines haemostatischen Praeparates |
-
0
- NL NL264722D patent/NL264722A/xx unknown
-
1961
- 1961-05-04 GB GB16266/61A patent/GB911727A/en not_active Expired
- 1961-05-12 DE DEC24100A patent/DE1225647B/de active Pending
- 1961-05-15 BE BE603790A patent/BE603790A/fr unknown
- 1961-05-16 FR FR861990A patent/FR1139M/fr not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1039708B (de) | 1953-05-19 | 1958-09-25 | Internat Hormones Inc | Verfahren zur Herstellung eines haemostatischen Praeparates |
Also Published As
| Publication number | Publication date |
|---|---|
| GB911727A (en) | 1962-11-28 |
| NL264722A (enrdf_load_stackoverflow) | |
| BE603790A (fr) | 1961-09-01 |
| FR1139M (fr) | 1962-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1795699B2 (de) | 1-(2-Hydroxyäthyl)-2-(4-fluorphenyl)-5-nitroimidazol, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel | |
| DE1170417B (de) | Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung | |
| DE1225647B (de) | Verfahren zum Herstellen von wasserloeslichen Komplexverbindungen des Isonicotinsaeurehydrazons | |
| CH449019A (de) | Verfahren zur Herstellung von neuen Hydrazinothiazolinen | |
| DE930927C (de) | Verfahren zur Herstellung von gut vertraeglichen Penicillin-Antihistamin-Komplexverbindungen mit verlaengerter Wirkung | |
| DE2247828A1 (de) | Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung | |
| DE1670539C3 (de) | Diacylthiamine und Verfahren zu deren Herstellung | |
| DE938249C (de) | Verfahren zur Herstellung von Dihydrocodeinhydrorhodanid | |
| DE2605650A1 (de) | Verfahren zur herstellung von para-isobutyl-phenylessigsaeurederivaten | |
| DE446782C (de) | Verfahren zur Gewinnung des herzwirksamen Reinglykosids aus Bulbus Scillae | |
| DE1795487C3 (de) | 5-Nitrofuran-Derivate. Ausscheidung aus: 1445556 | |
| US2317670A (en) | Bactericide and process of making the same | |
| DE896805C (de) | Verfahren zur Herstellung eines Testosteronesters | |
| DE1952800B2 (de) | 3,6-dimethyl-1,2,3,4,4a,9a-hexahydro-gamma-carbolin-dihydrochlorid | |
| AT146504B (de) | Verfahren zur Herstellung von Amiden der Pyrazinmonocarbonsäure. | |
| AT239790B (de) | Verfahren zur Herstellung neuer Hydrazino-triazine | |
| AT221503B (de) | Verfahren zur Herstellung neuer basischer Phenoläther und ihrer Salze | |
| DE947334C (de) | Verfahren zur Herstellung von Insulinpraeparaten mit einem Zinkgehalt von 0,5% und darunter | |
| DE651475C (de) | Verfahren zur Darstellung und Reinigung von OEstradiol | |
| DE947333C (de) | Verfahren zur Herstellung kristallisierter Inselhormonpraeparate | |
| DE1011880B (de) | Verfahren zur Herstellung von wenig toxischen Salzen von basischen Streptomycesantibiotika | |
| AT356274B (de) | Verfahren zur herstellung von festem 6-(d-alpha -amino-p-hydroxyphenyl- acetamido)-penicillansaeurenatriumsalz | |
| DE1445426C (de) | Verfahren zur Herstellnng von Den vaten der 2 Thiobarbitursaure | |
| DE1039708B (de) | Verfahren zur Herstellung eines haemostatischen Praeparates | |
| DE1023465B (de) | Verfahren zur Herstellung von Thiopyrimidinverbindungen |